货号:GS40806
Xeligekimab is an investigational humanized monoclonal antibody that selectively targets and neutralizes interleukin-17A (IL-17A). It is being developed for the treatment of moderate-to-severe plaque psoriasis and other IL-17-mediated autoimmune diseases, aiming to block the pro-inflammatory signaling of this key cytokine.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物